|
PLEKHA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.16499999980313E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.66250022029624E-10 |
| Normal-vs-Stage2 |
1.177810E-02 |
| Normal-vs-Stage3 |
1.313520E-02 |
| Normal-vs-Stage4 |
1.811200E-01 |
| Stage1-vs-Stage2 |
5.192600E-01 |
| Stage1-vs-Stage3 |
3.322700E-03 |
| Stage1-vs-Stage4 |
3.834700E-04 |
| Stage2-vs-Stage3 |
2.956800E-01 |
| Stage2-vs-Stage4 |
1.053610E-01 |
| Stage3-vs-Stage4 |
3.664800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.43560000553933E-08 |
| Normal-vs-AfricanAmerican |
7.758000E-01 |
| Normal-vs-Asian |
4.461200E-01 |
| Caucasian-vs-AfricanAmerican |
2.48339999999736E-05 |
| Caucasian-vs-Asian |
5.881600E-01 |
| AfricanAmerican-vs-Asian |
3.602600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.80139999999396E-05 |
| Normal-vs-Female |
1.86159999637781E-08 |
| Male-vs-Female |
1.002100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.666190E-01 |
| Normal-vs-Age(41-60Yrs) |
5.27630000024537E-07 |
| Normal-vs-Age(61-80Yrs) |
1.89292999999147E-05 |
| Normal-vs-Age(81-100Yrs) |
4.936500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.181400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.033000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.698200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.268600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.264200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.393600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.025900E-04 |
| Normal-vs-Grade 2 |
3.64909991112938E-10 |
| Normal-vs-Grade 3 |
1.188030E-04 |
| Normal-vs-Grade 4 |
9.188200E-01 |
| Grade 1-vs-Grade 2 |
2.048000E-01 |
| Grade 1-vs-Grade 3 |
1.199500E-02 |
| Grade 1-vs-Grade 4 |
3.65009999999666E-05 |
| Grade 2-vs-Grade 3 |
6.224600E-03 |
| Grade 2-vs-Grade 4 |
1.02360000031609E-07 |
| Grade 3-vs-Grade 4 |
3.441600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.11022302462516E-16 |
| Normal-vs-ccB subtype |
4.499600E-01 |
| ccA subtype-vs-ccB subtype |
2.44249065417534E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.08920000036528E-07 |
| Normal-vs-N1 |
1.892040E-01 |
| N0-vs-N1 |
6.669600E-01 |
|
|
